What could go wrong?
The donation amounts to 2.4 million bottles each year — but activists say it isn't enough.
A simple move from one class of inhibitor to another could decrease your risk of developing life-threatening diseases.
Testicular cancer impacts more men and boys than you realize, and the Testicular Cancer Foundation is hoping to change that.
A new study finds that HIV-associated cognitive impairments like dementia are being overdiagnosed.
Studies are showing that this drug could hit two birds with one stone.
The call for action comes because the government developed the use of Truvada as PrEP but Gilead Sciences is making all the money from it.